ライフサイエンスコーパス: IM-MS

1 IM MS(2) experiments provided strong evidence that the m

2 IM-MS data acquired for these two conformers were compar

3 IM-MS data on non-native conformers should therefore be

4 IM-MS distributions of the analogue peptides, when compa

5 IM-MS evidenced ADC multiple drug loading, collisional c

6 IM-MS measurement accuracy was confirmed by measurement

7 IM-MS measurements reveal that there are possibly three

8 IM-MS revealed that UBQLN2 exists as a mixture of monome

9 IM-MS shows the holo protein to exist in four closely re

10 IM-MS uniquely shows how within a single UMN population,

11 IM-MS yields collision cross section (CCS, Omega) values

12 from 12 to 22 carbons yields [2GA + 2Na](2+) IM-MS profiles with reduced conformer microheterogeneity

13 Two-dimensional (2D) IM-MS trend lines are compared with model polymer system

14 reproducibility of such measurements across IM-MS platforms, and the correlation between CIU and dif

15 An IM-MS workflow applied to a given target analyte provide

16 or the synthesis of N-glycans assisted by an IM-MS analysis approach for rapid screening of optimized

17 lexes, we outline the typical features of an IM-MS experiment from the preparation of samples, the cr

18 cording to a highly convergent approach, and IM-MS and IRMPD-MS data were second collected.

19 er, our results illustrate how native MS and IM-MS can rapidly assess ADC structural heterogeneity an

20 However, while both LC-MS and IM-MS have clearly proven their individual capabilities

21 Consequently, combined LC-MS and IM-MS offer a superior approach for the characterization

22 Hence, LC-MS and IM-MS unveiled complementary compositional insight.

23 Native MS and IM-MS will play an increasing role in next generation bi

24 were collected and analyzed by native MS and IM-MS, assessing the interpretation of each HIC peak.

25 ion mobility-mass spectrometry (IM-MS), and IM-MS/MS in conjunction with computational methods.

26 Application of MALDI-MS, ESI-MS, and IM-MS to the polymer-peptide biomaterial confirmed its c

27 nefits of combining state-of-the-art nMS and IM-MS approaches to address challenging issues encounter

28 ese results highlight the utility of SID and IM-MS in resolving conformational heterogeneity and yiel

29 Atmospheric-pressure (AP) IM-MS offers an advantage in these studies compared to i

30 te the application of the pulsed nano-ESI AP-IM-MS with enhanced ion sampling for detection of solven

31 sensitivity and soft ion introduction in AP-IM-MS.

32 from a approximately 0.9-m drift tube-based IM-MS platform operated at the same pressure (4 Torr).

33 Broad IM-MS collision cross section (CCS) mapping (n > 300) an

34 nd finally, we focus on insights afforded by IM-MS experiments when applied to the study of conformat

35 y of a large heteromeric complex analysed by IM-MS, coupled with integrative modelling, highlights th

36 n the subresidue-level resolution enabled by IM-MS-coupled carbene footprinting can bridge the gap be

37 Collision cross sections (CCSs) measured by IM-MS provide a measure of analyte size.

38 isomers were consequently fully resolved by IM-MS, and the relative ratio of the isomers was determi

39 of using gas-phase structural separations by IM-MS for the characterization of AuNPs, revealing signi

40 The structures defined in this study by IM-MS/MS agree with those found in the past but use much

41 trostatic fields commonly used in drift cell IM-MS instruments.

42 ng CCS data is well developed for drift cell IM-MS, while strategies for obtaining CCS values from t-

43 lipids measured using t-wave and drift cell IM-MS, while this improves to <0.5% when drift cell phos

44 CCS calibrants measured by MALDI drift cell IM-MS.

45 .7%, respectively, whereas the hybrid MS-CID-IM-MS approach yields amino acid sequence coverages of 8

46 14.3 kDa) demonstrates the ability of MS-CID-IM-MS to rapidly identify the presence and sites of modi

47 The MS-CID-IM-MS top-down approach allows for greater depth of info

48 n proteomics is described, denoted as MS-CID-IM-MS.

49 etter resolved than with existing commercial IM-MS platforms.

50 wever, most of the currently used commercial IM-MS instruments utilize a nonuniform traveling wave fi

51 In this report, we describe a comprehensive IM-MS and CIU dataset acquired for three Infliximabs: Re

52 Furthermore, we collected our comprehensive IM-MS and CIU data across two instrument platforms (Wate

53 Here, we describe a method that couples IM-MS and surface-induced dissociation (SID) to dissocia

54 yogenic ion mobility-mass spectrometry (cryo-IM-MS) measurements.

55 yogenic ion mobility-mass spectrometry (cryo-IM-MS) show that dehydration of alkyl diammonium cations

56 er illustrate that a combined data-dependent IM-MS/MS approach for phosphopeptide screening would hav

57 fer reactions (CAPTR), with energy-dependent IM-MS and varied solution conditions to probe their comb

58 Energy-dependent IM-MS, e.g., collision-induced unfolding (CIU), has been

59 ity mass spectrometry-mass spectrometry (DIA-IM-MS) was used to investigate the allergen composition

60 these compounds, we employed three different IM-MS platforms (Agilent 6560 IM-QToF, Waters Synapt G2,

61 ected between sample treatment groups by DPM-IM-MS, many of which were not previously detected with c

62 not previously detected by single-pulse DPM-IM-MS.

63 Employing the DPM-IM-MS method to adherent cells yielded the detection of

64 DT IM-MS, in combination with molecular dynamics (MD), show

65 rift time ion mobility mass spectrometry (DT IM-MS) in addition to circular dichroism spectroscopy.

66 H 6.8 with 20 mM ammonium acetate, in the DT IM-MS instrument, each buffer gas can yield a different

67 m CCS measured in helium via drift tube (DT) IM-MS.

68 DT-IM-MS experiments at 200 K resolve multiple conformers.

69 t time ion mobility mass spectrometry (VT-DT-IM-MS).

70 nization ion mobility mass spectrometry (ESI IM-MS) and molecular dynamics (MD) simulations reveal ne

71 For these host:guest adducts, the ESI IM-MS studies revealed that [1](4+) is expanded by 47-49

72 ESI-IM-MS reveals the presence of multiple conformers for th

73 Finally, we present an ESI-IM-MS methodology to determine if a given protein is str

74 been unequivocally characterized by NMR, ESI-IM-MS, and TEM techniques.

75 nization ion mobility-mass spectrometry (ESI-IM-MS) and collision-induced unfolding (CIU) analysis of

76 nization-ion mobility-mass spectrometry (ESI-IM-MS), successfully demonstrates the first evidence for

77 rating that distributions observed using ESI-IM-MS unambiguously reflect the ensemble of conformers o

78 VCFD-ESI-IM-MS yields novel biophysical insight into the influenc

79 tion: "If the only technique you had was ESI-IM-MS, what information would it provide on the structur

80 It remains unclear to what extent IM-MS is suitable for exploring structural properties of

81 ies and strains are found within both the FI-IM-MS and HILIC-IM-MS data sets.

82 -to-head comparison demonstrates that the FI-IM-MS multiomic strategy performs similarly to LC-IM-MS

83 Advantages of LC/IM-MS and FIA/IM-MS include the ability to develop mobility-mass trend

84 des: flow injection analysis with IM-MS (FIA/IM-MS), LC/MS, and LC/IM-MS.

85 Finally, IM-MS can be used to gain insights into the conformation

86 lishes a new type of inorganic calibrant for IM-MS allowing sizing, structural analysis, and discover

87 n three analytical measurements derived from IM-MS (collision cross section, CCS), mass-to-charge (m/

88 Because comparing CCS derived from IM-MS data with 3D-computed CCS is critical for thorough

89 The use of CCSs, measured from IM-MS and molecular modeling information, for the struct

90 t of a wide range of contemporary and future IM-MS experiments.

91 o the limited resolution of first-generation IM-MS instruments, subtle conformational differences on

92 HDX-IM-MS data indicated the presence of multiple gas-phase

93 are found within both the FI-IM-MS and HILIC-IM-MS data sets.

94 reproducible and efficient analysis of HILIC-IM-MS lipidomics data, we developed an open-source Pytho

95 graphy-ion mobility-mass spectrometry (HILIC-IM-MS) has shown advantages in separating lipids through

96 procainamide-labeled GSL glycans using HILIC-IM-MS and a new, automated glycan identification strateg

97 re, using this data set, we demonstrated how IM-MS can be used to conveniently characterize and ident

98 This Review critically describes how IM-MS has been used to enhance various areas of chemical

99 Our results illustrate how IM-MS can rapidly assess bsAb structural heterogeneity a

100 mAbs, paving the way for more widespread HR-IM-MS/CIU characterization of mAb-derived formats.

101 nstrument is based on a Waters SYNAPT G2-S i IM-MS platform, with the IM separation region modified t

102 Despite recent advances in IM-MS instrumentation, the resolution of closely related

103 strated in solution, it is not detectable in IM-MS.

104 entical solution conditions to those used in IM-MS.

105 ther tested the feasibility of incorporating IM-MS into conventional LC/MS metabolomics workflows.

106 er and analyzed using a rapid flow injection-IM-MS method.

107 bility-mass spectrometry was added (i.e., LC-IM-MS) as an additional selectivity filter without exten

108 atography/ion mobility/mass spectrometry (LC-IM-MS) data, providing a route to quantify ion mobility

109 raphy and ion mobility mass spectrometry (LC-IM-MS) demonstrated successful integration of the glycos

110 multiomic strategy performs similarly to LC-IM-MS in its ability to distinguish 24 strains of the hi

111 alysis with IM-MS (FIA/IM-MS), LC/MS, and LC/IM-MS.

112 were analyzed and validated using a 2 min LC/IM-MS method.

113 Advantages of LC/IM-MS and FIA/IM-MS include the ability to develop mobil

114 rift tube ion mobility-mass spectrometer (LC/IM-MS) was evaluated for its utility in global metabolom

115 samples shows good agreement between this LC/IM-MS and traditional LC/MS/MS methods.

116 structural information provided by CCS make IM-MS a promising technique for obtaining more structura

117 es can be preserved in the gas phase, making IM-MS a powerful approach for a range of bioanalytical a

118 zation ion mobility mass spectrometry (MALDI-IM-MS) allows a pixel-by-pixel classification and identi

119 zation-ion mobility-mass spectrometry (MALDI-IM-MS) was used to analyze low mass gold-thiolate fragme

120 xperiments are similar to those used in many IM-MS instruments, therefore, the outcomes of this resea

121 ation of mass spectrometry and ion mobility (IM-MS), are also instructive in exploring conformational

122 pectrometry (MS) and native ion mobility MS (IM-MS) is compared to hydrophobic interaction chromatogr

123 ) techniques, namely native ion mobility MS (IM-MS), collision-induced unfolding (CIU), and hydrogen-

124 energy-resolved MS (ERMS), ion mobility-MS (IM-MS), and computational modeling, to characterize 14 c

125 Native IM-MS was next used for the first time to characterize a

126 bal shape information from tmFRET and native IM-MS, respectively, confirmed Cu(II) displacement towar

127 mbedded alphaHL porelike complexes by native IM-MS without the need to fully strip the detergent mice

128 (CCS) values were then determined by native IM-MS, which could separate the conformations of Cu-boun

129 isation ion mobility-mass spectrometry (nESI-IM-MS), we characterize the heterogeneous interactions o

130 ization-ion mobility-mass spectrometry (nESI-IM-MS).

131 has essentially precluded the application of IM-MS methods to large particles and complexes with mass

132 The assessment of IM-MS data, however, is currently impeded due to the lac

133 prior reports detailing the capabilities of IM-MS and CIU to differentiate biosimilars, generic mAb

134 For UMNs, comparison of IM-MS results with TEM and N(2) physisorption yields qua

135 ection distributions to allow comparisons of IM-MS data for commonly analyzed proteins.

136 As the first commercialized form of IM-MS, Traveling Wave Ion Mobility (TWIM) devices are op

137 A semiquantitative interpretation of IM-MS data was developed to directly extrapolate average

138 In total, we demonstrate the potential of IM-MS as a standard approach for the characterization of

139 biomolecules, however, the full potential of IM-MS in their study has yet to be realized due to a lac

140 A series of IM-MS experiments were able to separate the low abundanc

141 Here, we demonstrate the use of IM-MS to probe the early stages of aggregate formation o

142 etry (IM-MS) have accelerated the utility of IM-MS in untargeted, discovery-driven studies in biology

143 iffusion, and may not be feasible for online IM-MS analyses.

144 Altogether, optimized IM-MS settings allowed a 0.4 nm(2) increase (i.e., 2%) o

145 scribe a series of detailed and quantitative IM-MS and CIU data sets that reveal HOS details associat

146 his in vitro biosynthesis coupled with rapid IM-MS analysis workflow represents a promising platform

147 n when compared with any previously reported IM-MS platforms, allowing for comprehensive unfolding of

148 tance constraints (tmFRET) and global shape (IM-MS) provide additional structural insights of SST and

149 on mobility-mass spectrometry platform (SLIM IM-MS), in conjunction with serpentine ultralong path wi

150 After initial optimization, the SLIM IM-MS module provided about 5-fold higher resolution sep

151 The high resolution achieved in the TW SLIM IM-MS enabled, e.g., isomeric sugars (lacto-N-fucopentao

152 ation source ion mobility-mass spectrometer (IM-MS) instrument platform for investigations that criti

153 An ion mobility-mass spectrometer (IM-MS) interface is described that can be employed to pe

154 acterized by ion mobility mass spectrometry (IM MS) and tandem mass spectrometry (MS(2)).

155 Ion mobility-mass spectrometry (IM-MS) affords unique advantages for probing the conform

156 Ion mobility mass spectrometry (IM-MS) allows separation of native protein ions into "co

157 n (ESI) with ion mobility-mass spectrometry (IM-MS) allows structural studies on biological macromole

158 on have made ion mobility-mass spectrometry (IM-MS) an increasingly popular approach for the structur

159 idimensional ion mobility-mass spectrometry (IM-MS) analytical platform and in-solution kinetics anal

160 ditions with ion mobility-mass spectrometry (IM-MS) and collision-induced unfolding (CIU) technologie

161 velopment of ion mobility-mass spectrometry (IM-MS) and collision-induced unfolding (CIU) workflows t

162 mbination of ion-mobility mass spectrometry (IM-MS) and hydrogen/deuterium exchange mass spectrometry

163 ch utilizing ion mobility-mass spectrometry (IM-MS) and tandem mass spectrometry (MS/MS) coupled with

164 stic, native ion mobility-mass spectrometry (IM-MS) and transition metal ion Forster resonance energy

165 ) and native ion mobility-mass spectrometry (IM-MS) approach to characterize the structure of mass- a

166 on (LDI) and ion mobility mass spectrometry (IM-MS) are applied to study molecular weight distributio

167 Ion mobility-mass spectrometry (IM-MS) can provide orthogonal information, i.e., m/z and

168 Ion mobility-mass spectrometry (IM-MS) can thus act as a tool to separate complex mixtur

169 sulting from ion mobility-mass spectrometry (IM-MS) experiments provide a promising orthogonal dimens

170 m untargeted ion mobility-mass spectrometry (IM-MS) experiments.

171 ing CID with ion mobility mass spectrometry (IM-MS) for dispersing fragment ions along charge state s

172 fluidics and ion mobility mass spectrometry (IM-MS) for single-cell metabolite detection and identifi

173 Ion mobility-mass spectrometry (IM-MS) has become a powerful tool for glycan structural

174 Ion mobility-mass spectrometry (IM-MS) has become an important addition to the structura

175 re recently, ion mobility mass spectrometry (IM-MS) has emerged as an effective tool for gas-phase se

176 Ion mobility-mass spectrometry (IM-MS) has gained considerable attention for detection o

177 ation of ion mobility and mass spectrometry (IM-MS) has greatly enlarged the potentials for biomolecu

178 m ion mobility coupled to mass spectrometry (IM-MS) have accelerated the utility of IM-MS in untarget

179 lision cross section with mass spectrometry (IM-MS) helps, but many isomers are still difficult to se

180 Ion mobility-mass spectrometry (IM-MS) in combination with molecular modeling offers the

181 e drift tube ion mobility-mass spectrometry (IM-MS) instrument and utilizes both an existing ion mult

182 c drift tube ion mobility-mass spectrometry (IM-MS) instrument.

183 lable hybrid ion mobility-mass spectrometry (IM-MS) instruments in 2006, IMS technology became readil

184 Ion mobility-mass spectrometry (IM-MS) is a powerful technique for structural characteri

185 coupled with ion mobility mass spectrometry (IM-MS) is a powerful tool for determining the stoichiome

186 Ion mobility-mass spectrometry (IM-MS) is a rapid, two-dimensional analysis that separat

187 Ion mobility-mass spectrometry (IM-MS) is a technology of growing importance for structu

188 Native ion mobility-mass spectrometry (IM-MS) is capable of revealing much that remains unknown

189 rein, native ion mobility mass spectrometry (IM-MS) is employed to measure the intrinsic dynamic prop

190 Unique to ion mobility mass spectrometry (IM-MS) is the ability to provide collision cross section

191 Here, native ion mobility-mass spectrometry (IM-MS) is used to compare the gas phase stabilities and

192 e feature of ion mobility mass spectrometry (IM-MS) lies in its ability to provide experimental colli

193 (CCSs) from ion mobility mass spectrometry (IM-MS) measurements are routinely compared to computatio

194 Ion mobility-mass spectrometry (IM-MS) measurements showed that folded protein conformat

195 ination with ion mobility-mass spectrometry (IM-MS) measurements, distinguish subtly different confor

196 blished from ion mobility mass spectrometry (IM-MS) measurements.

197 nstrate that ion mobility mass spectrometry (IM-MS) overcomes these limitations.

198 80 (SLIM-OE) ion mobility mass spectrometry (IM-MS) platform was developed, integrating SLIM IM separ

199 Ion mobility-mass spectrometry (IM-MS) provides rapid two-dimensional separation of ions

200 Ion mobility-mass spectrometry (IM-MS) provides rapid two-dimensional separations based

201 aveling wave ion mobility mass spectrometry (IM-MS) revealed an N -> O peptidyl shift in singly proto

202 Ion mobility mass spectrometry (IM-MS) showed that the two isolated oligosaccharides hav

203 r structural ion mobility-mass spectrometry (IM-MS) studies is demonstrated using model peptide ions

204 A recent ion mobility-mass spectrometry (IM-MS) study of the nonapeptide bradykinin (BK, amino ac

205 olding (CIU) ion mobility-mass spectrometry (IM-MS) that ncUbq exhibits structural preferences and in

206 derived from ion mobility mass spectrometry (IM-MS) to build three-dimensional models of one form of

207 n the use of ion mobility mass spectrometry (IM-MS) to investigate conformations of proteins and prot

208 ogether with ion mobility mass spectrometry (IM-MS) to study soluble preamyloid oligomers.

209 Ion mobility mass spectrometry (IM-MS) was used to probe the structures of several metal

210 Ion-mobility mass spectrometry (IM-MS) was used to separate these structures and, signif

211 using native ion mobility-mass spectrometry (IM-MS) we find that alphaHL simultaneously forms hexamer

212 nization and ion mobility mass spectrometry (IM-MS) were unsuccessfully used in order to resolve the

213 obtained by ion mobility-mass spectrometry (IM-MS), 2D NMR spectroscopy, and computational methods.

214 Recently, ion mobility-mass spectrometry (IM-MS), a technique in which ions are separated accordin

215 opy, ESI-MS, ion-mobility mass spectrometry (IM-MS), AFM, and TEM.

216 issociation, ion mobility mass spectrometry (IM-MS), and density functional theory (DFT) has been use

217 try (MS/MS), ion mobility-mass spectrometry (IM-MS), and IM-MS/MS in conjunction with computational m

218 ric-pressure ion mobility-mass spectrometry (IM-MS), and we demonstrate the analytical capability of

219 y ionization-ion mobility-mass spectrometry (IM-MS), collision-induced dissociation (CID), and hydrog

220 plemented as ion mobility-mass spectrometry (IM-MS), comprises two sequential, gas-phase dispersion t

221 re, we apply ion mobility mass spectrometry (IM-MS), density functional theory (DFT), and mass-select

222 we show how ion mobility mass spectrometry (IM-MS), in combination with tandem mass spectrometry, co

223 ometry (MS), ion mobility mass spectrometry (IM-MS), small-angle neutron and X-ray scattering (SANS a

224 Ion mobility-mass spectrometry (IM-MS), tandem mass spectrometry (MS/MS), and computatio

225 es employing ion-mobility mass spectrometry (IM-MS), the apparent controversy is resolved.

226 utility with ion-mobility mass spectrometry (IM-MS), the use of RP-MS data to help model protein comp

227 , native MS, ion mobility mass spectrometry (IM-MS), together with collision-induced unfolding and a

228 antly, using ion mobility-mass spectrometry (IM-MS), we find that all four macromolecular complexes r

229 coli, using ion mobility mass spectrometry (IM-MS), which reports gas-phase collision cross-sections

230 The use of ion mobility-mass spectrometry (IM-MS), which separates ions in the gas phase based on t

231 ins based on ion mobility-mass spectrometry (IM-MS).

232 using native ion mobility-mass spectrometry (IM-MS).

233 using native ion mobility mass spectrometry (IM-MS).

234 ogy with ion mobility and mass spectrometry (IM-MS).

235 ique such as ion mobility-mass spectrometry (IM-MS).

236 (MS(2)), and ion mobility mass spectrometry (IM-MS).

237 try (MS) and ion mobility mass spectrometry (IM-MS).

238 ion of MS(2) with ion mobility spectrometry (IM-MS(2)) and lead to a strategy to distinguish alpha- a

239 The multipass SUPER IM-MS provided resolution approximately proportional to

240 Activated tandem IM-MS reveals the oligomer disassembly in detail, highli

241 Variable-temperature IM-MS is here shown to be an exciting approach to discer

242 The results present that IM-MS and molecular modeling can inform on the identity

243 We show that IM-MS yields a 2D particle size-mass distribution functi

244 We show that IM-MS/MS analysis can rapidly and accurately differentia

245 The IM MS/MS(2) methods provide a means to analyze, based on

246 The IM-MS instrument operation is independent of which ioniz

247 The IM-MS interface consists of a stacked-ring ion guide des

248 turn, qualifies as a means in evaluating the IM-MS data.

249 ional changes that are not apparent from the IM-MS data alone.

250 From the IM-MS data coupled with theoretical calculations, it was

251 and collisional activation processes in the IM-MS interface are described as a function of the ion-n

252 Integrating the IM-MS and MD data provides a global view that shows step

253 DFT structures, in good agreement with the IM-MS cross sections, indicate two "bent" conformations

254 tion (10-30 mus) ion pulses for use with the IM-MS.

255 easurements from seven proteins across three IM-MS configurations, namely, an Agilent 6560 IMQToF, a

256 d capillary reverse phase columns coupled to IM-MS.

257 The results also suggest that the total IM-MS distribution for a protein is the complex result o

258 eport the development of a unique drift tube IM-MS (DTIM-MS) platform, which combines high-energy sou

259 a home-built variable temperature drift tube IM-MS) and used them to investigate six different genera

260 In this work, both DT and TW IM-MS instruments are used to investigate the effects of

261 mmon to use nitrogen as the buffer gas in TW IM-MS instruments and to calibrate by extrapolating from

262 oglobin, frequently used as a standard in TW IM-MS studies.

263 ling wave ion mobility mass spectrometry (TW IM-MS) instrumentation rely on the use of calibrants to

264 3 and 4 which demonstrate their use as a TW-IM-MS calibrant set to facilitate characterization of ve

265 Traveling wave IM-MS (TW-IM-MS) has recently become commercially available to non

266 ling-wave ion mobility-mass spectrometry (TW-IM-MS).

267 inally, as proof of concept, we used UPLC-TW-IM-MS to compare the cellular metabolome of epithelial a

268 liquid chromatography (UPLC) coupled with TW-IM-MS.

269 resent work, we aimed at developing a unique IM-MS-based approach for the characterization of mAb sub

270 ography-ion mobility-mass spectrometry (UPLC-IM-MS) method was optimized for fecal samples derived fr

271 Utilizing the UPLC-IM-MS method, we were able to identify dysregulation of

272 ristearates were, however, not observed upon IM-MS.

273 Here, we use IM-MS to measure the conformational consequences of char

274 By using IM-MS, we could detect the native mass of MscL from Esch

275 ucture-function relationships of drugs using IM-MS.

276 structural isomers of drug metabolites using IM-MS is demonstrated and, in addition, a molecular mode

277 unknowns in non-targeted metabolomics using IM-MS to focus and provide insights into areas requiring

278 y monitoring the conformer preferences using IM-MS.

279 Utilizing IM-MS, statistical analysis, and targeted ultraperforman

280 ere obtained, and on a TWIMS Q-TOF utilizing IM-MS software rates up to 33 Hz are demonstrated.

281 UVPD-IM-MS analysis serves both as a method for peptide seque

282 to expand the field of protein analysis via IM-MS.

283 VT-IM-MS is used here to investigate the change in the conf

284 ions present two distinct conformers and VT-IM-MS measurements allow us to calculate the transition

285 tures of this instrument and results from VT-IM-MS experiments on a range of model systems-IMS CCS st

286 mperature ion mobility mass spectrometry (VT-IM-MS) to study the effect of temperature on the stabili

287 ategies for obtaining CCS values from t-wave IM-MS data remains an active area of research.

288 ly from thin tissue sections by MALDI t-wave IM-MS using CCS calibrants measured by MALDI drift cell

289 Traveling wave IM-MS (TW-IM-MS) has recently become commercially availa

290 rogen on the widely available traveling wave IM-MS (TWIM-MS) platform.

291 ially available drift tube or traveling wave IM-MS platforms.

292 Recently, traveling-wave (t-wave) IM-MS was developed which uses electrodynamic rather tha

293 l, we explored in the present report whether IM-MS can be used to differentiate close conformers and

294 With IM-MS, the total surfactant ions were separated accordin

295 peration modes: flow injection analysis with IM-MS (FIA/IM-MS), LC/MS, and LC/IM-MS.

296 c conformational tightening, consistent with IM-MS data.

297 resent an in vitro biosynthesis coupled with IM-MS strategy for rapid generation and analysis of drug

298 teraction liquid chromatography (HILIC) with IM-MS to analyze the glycan structures released from hum

299 We conclude that mining the PDB with IM-MS data is a time-effective way to derive low-resolut

300 Combining RAPTOR with IM-MS and collision-induced dissociation (CID) enables u